Sune Justesen PhD

Sune Justesen has a Ph.D. from the University of Copenhagen. For more than a decade he was responsible for maintaining and developing the probably largest recombinant MHC platform in the laboratory of Dr. Søren Buus. The molecules where used in sensitive peptide binding assays to generate data, that where subsequently used to develop best in class prediction tools for assessing peptide binding to MHC molecules (NetMHC and others). These predictors have proven as invaluable tools in the field of immunology.

The know-how and technology was recently spun out into the company Immunitrack, where Dr. Justesen serves as CSO.